Humacyte Inc (HUMA)

$1.47 -0.03 (-2.00%)
Market Cap 232.81M
Revenue (ttm) 0.00
Net Income (ttm) -148.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,180,400
Avg Vol 4,581,278
Day's Range N/A - N/A
Shares Out 158.37M
Stochastic %K 50%
Beta 1.87
Analysts Strong Sell
Price Target $8.43

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
flanny111
flanny111 Sep. 13 at 11:42 PM
$HUMA does the five day chart look like a bull flag or am I just making shit up?
0 · Reply
Akwaba76
Akwaba76 Sep. 13 at 8:47 PM
$HUMA
0 · Reply
Akwaba76
Akwaba76 Sep. 13 at 8:36 PM
$HUMA https://www.jvscit.org/article/S2468-4287(25)00258-8/fulltext
0 · Reply
flanny111
flanny111 Sep. 13 at 5:47 PM
$HUMA for fuck sake please just announce something juicy this week
1 · Reply
Akwaba76
Akwaba76 Sep. 13 at 5:38 PM
$HUMA They don’t have to issue anything immediately; this gives them the option, they don't have to use it all at once either.
0 · Reply
sorind
sorind Sep. 13 at 5:11 PM
$HUMA 30% down on Monday?
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Sep. 13 at 4:44 PM
$HUMA , HUMAW : So it's only a 140,000,000 Shares Dilution? It's not like anyone wants these to move, right?
0 · Reply
TheVirus0011
TheVirus0011 Sep. 13 at 12:01 PM
$HUMA Hello, is this a dilution? https://investors.humacyte.com/node/10166/html
1 · Reply
Akwaba76
Akwaba76 Sep. 13 at 6:14 AM
$HUMA https://vascularnews.com/past-issues/
0 · Reply
DonCorleone77
DonCorleone77 Sep. 12 at 10:57 PM
$HUMA Humacyte files $350M mixed securities shelf
0 · Reply
Latest News on HUMA
Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress

Aug 12, 2025, 1:20 PM EDT - 4 weeks ago

Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 10:00 AM EDT - 4 weeks ago

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

Aug 11, 2025, 7:00 AM EDT - 4 weeks ago

Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Aug 7, 2025, 8:00 AM EDT - 5 weeks ago

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

Humacyte Announces First Symvess™ Sale to Military Treatment Facility

Jul 23, 2025, 8:00 AM EDT - 7 weeks ago

Humacyte Announces First Symvess™ Sale to Military Treatment Facility

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Jul 8, 2025, 8:00 AM EDT - 2 months ago

Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency

Humacyte: Revenue Ramp From Symvess Incoming

Jun 11, 2025, 9:05 AM EDT - 3 months ago

Humacyte: Revenue Ramp From Symvess Incoming

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Jun 9, 2025, 8:00 AM EDT - 3 months ago

Results from Humacyte's V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

Jun 2, 2025, 8:00 AM EDT - 3 months ago

Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq

May 19, 2025, 4:05 PM EDT - 4 months ago

Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

May 13, 2025, 2:29 PM EDT - 4 months ago

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

May 13, 2025, 7:30 AM EDT - 4 months ago

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

May 9, 2025, 8:00 AM EDT - 4 months ago

Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

Mar 28, 2025, 1:48 PM EDT - 6 months ago

Humacyte, Inc. (HUMA) Q4 2024 Earnings Conference Call Transcript

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Mar 28, 2025, 7:30 AM EDT - 6 months ago

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Mar 26, 2025, 8:00 AM EDT - 6 months ago

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Mar 25, 2025, 8:35 PM EDT - 6 months ago

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Mar 25, 2025, 4:01 PM EDT - 6 months ago

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Mar 10, 2025, 8:00 AM EDT - 6 months ago

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Trestle Bio Announces Research Collaboration with Humacyte

Mar 6, 2025, 8:00 AM EST - 6 months ago

Trestle Bio Announces Research Collaboration with Humacyte

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Mar 3, 2025, 8:00 AM EST - 6 months ago

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 4:05 PM EST - 7 months ago

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Feb 27, 2025, 8:00 AM EST - 7 months ago

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Feb 26, 2025, 8:00 AM EST - 7 months ago

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Humacyte, Inc. - Investors of Humacyte Stock Encouraged to Contact Kehoe Law Firm, P.C. - HUMA

Feb 20, 2025, 1:35 PM EST - 7 months ago

Humacyte, Inc. - Investors of Humacyte Stock Encouraged to Contact Kehoe Law Firm, P.C. - HUMA

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

Jan 21, 2025, 8:00 AM EST - 8 months ago

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Jan 17, 2025, 10:30 AM EST - 8 months ago

HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA

Jan 9, 2025, 5:45 AM EST - 8 months ago

Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

Jan 2, 2025, 8:15 AM EST - 9 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte

flanny111
flanny111 Sep. 13 at 11:42 PM
$HUMA does the five day chart look like a bull flag or am I just making shit up?
0 · Reply
Akwaba76
Akwaba76 Sep. 13 at 8:47 PM
$HUMA
0 · Reply
Akwaba76
Akwaba76 Sep. 13 at 8:36 PM
$HUMA https://www.jvscit.org/article/S2468-4287(25)00258-8/fulltext
0 · Reply
flanny111
flanny111 Sep. 13 at 5:47 PM
$HUMA for fuck sake please just announce something juicy this week
1 · Reply
Akwaba76
Akwaba76 Sep. 13 at 5:38 PM
$HUMA They don’t have to issue anything immediately; this gives them the option, they don't have to use it all at once either.
0 · Reply
sorind
sorind Sep. 13 at 5:11 PM
$HUMA 30% down on Monday?
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Sep. 13 at 4:44 PM
$HUMA , HUMAW : So it's only a 140,000,000 Shares Dilution? It's not like anyone wants these to move, right?
0 · Reply
TheVirus0011
TheVirus0011 Sep. 13 at 12:01 PM
$HUMA Hello, is this a dilution? https://investors.humacyte.com/node/10166/html
1 · Reply
Akwaba76
Akwaba76 Sep. 13 at 6:14 AM
$HUMA https://vascularnews.com/past-issues/
0 · Reply
DonCorleone77
DonCorleone77 Sep. 12 at 10:57 PM
$HUMA Humacyte files $350M mixed securities shelf
0 · Reply
crowbaby333
crowbaby333 Sep. 12 at 9:26 PM
$HUMA s-3 filing is nothing new. Must replace every 3 years. But it does say they have cash until Aug 2026
3 · Reply
Mandaloolu
Mandaloolu Sep. 12 at 7:40 PM
$HUMA Accumulation time, like for the past year lol
0 · Reply
flanny111
flanny111 Sep. 12 at 6:29 PM
$HUMA also I wonder if that guy is gonna buy 100k shares at the closing bell like they have been the last couple days
0 · Reply
flanny111
flanny111 Sep. 12 at 6:29 PM
$HUMA the chart looks like a bull flag. Hasn’t dipped under 1.46 today. I Wonder if we resume uptrend next week.
0 · Reply
crowbaby333
crowbaby333 Sep. 12 at 6:28 PM
$HUMA I have sold puts, and calls right now for Jan 16. Here is why.... I think dilution comes after Jan. Like Feb/March. Q3 Sales Results may double 1H. Department of Defense is biting. (report) Humacyte has reiterated many times, as recently as investor call they plan to submit an IND in 2025 for a first-in-human (FIH) clinical study of the sdATEV for aCoronary Artery Bypass product line. HUGE TAM.
1 · Reply
gtzmoney
gtzmoney Sep. 12 at 2:24 PM
$HUMA wake up
0 · Reply
Barnieshytles
Barnieshytles Sep. 12 at 1:41 PM
$HUMA I kinda want to throw a green dildo on to this stock. Maybe then more people will pay attention to it.
2 · Reply
Musky49
Musky49 Sep. 12 at 1:27 PM
$HUMA Man, this applies here https://hbr.org/podcast/2025/09/when-fake-news-targets-your-company
0 · Reply
moneyisfunduhr
moneyisfunduhr Sep. 12 at 1:00 PM
$HUMA we need to break past $1.5 to confirm an up momentum. Otherwise this will stay in a boring consolidation range.
1 · Reply
Rocketstockz
Rocketstockz Sep. 12 at 12:41 PM
$HUMA today’s the day only up from here
0 · Reply
rubraquercus
rubraquercus Sep. 12 at 11:52 AM
$HUMA This where the money gets made
0 · Reply
Tripl3R
Tripl3R Sep. 12 at 3:03 AM
$HUMA made a great move today, time to average down on HUMA. Road to 100k shares of Huma 😎
1 · Reply